Honey, renowned for its nutritional and therapeutic properties, has recently come under scrutiny due to its contamination by microplastics, in multiple ways. Bees’ exposure to plastic pollution impacts the whole hive’s ecosystem, and plastic tends to accumulate in hive products. Plastic packaging as polyethylene terephthalate (PET) is used to store honey in small flexible packages, which also increases the risk of microplastic migration. This study aims to establish three practical detection methods for PET microplastics and nanoplastics in honey, using readily available laboratory equipment without the need for chemical digestion or costly pretreatment protocols, in a laboratory-based simulation. The first method utilizes Raman micro-spectroscopy, offering high-resolution identification of PET microplastics on cellulose acetate filters with Raman mapping, eliminating the need for organic solvents or dyes. The second method employs optical microscopic observation under fluorescence with the aid of 4-dimethylamino-4′-nitrostilbene dye and ultraviolet radiation to enhance microplastic visibility, making it suitable for laboratories with standard optical microscopes. To isolate MPs from the solid honey particles, a density separator has been introduced using pentane. Lastly, the third method employs the use of electrospray ionization mass spectrometry for the detection of nanoplastics (<200 nm) in honey samples, through the examination of the different extraction phases of density separation. All the aforementioned methods contribute to efficient microplastic detection in honey, ensuring its quality and safe consumption.
One major public health issue is cancer chemotherapy; despite constant progress in the area, administration of anticancer drugs to patients is often associated with serious side effects. It is therefore imperative to develop vehicles for encapsulation and controlled delivery of such drugs. Anticancer drugs include small peptide drugs, such as Bortezomib (BTZ). Self-assembling peptides have been recently reported as promising drug delivery agents. The research reported here proposes the encapsulation of BTZ into peptide hydrogels formed by the self-assembling FmocFF dipeptide as delivery vehicle. We selected FmocFF as an encapsulation vehicle based on our previous simulation study on the complexation propensity of Bortezomib (BTZ) with various peptide gelators. Herein we undertook additional computational studies that highlight the benefits of FmocFF as a potential effective nanocarrier for BTZ combined with experiments of encapsulation and evaluation of BTZ release. Based on these computational and experimental results, we propose the Fmoc-FF dipeptide hydrogel as a promising matrix for the controlled delivery of BTZ.
SUMMARY: Exo70B1 is a protein subunit of the exocyst complex with a crucial role in a variety of cell mechanisms, including immune responses against pathogens. The calcium‐dependent kinase 5 (CPK5) of Arabidopsis thaliana (hereafter Arabidopsis), phosphorylates AtExo70B1 upon functional disruption. We previously reported that, the Xanthomonas campestris pv. campestris effector XopP compromises AtExo70B1, while bypassing the host's hypersensitive response, in a way that is still unclear. Herein we designed an experimental approach, which includes biophysical, biochemical, and molecular assays and is based on structural and functional predictions, utilizing AplhaFold and DALI online servers, respectively, in order to characterize the in vivo XccXopP function. The interaction between AtExo70B1 and XccXopP was found very stable in high temperatures, while AtExo70B1 appeared to be phosphorylated at XccXopP‐expressing transgenic Arabidopsis. XccXopP revealed similarities with known mammalian kinases and phosphorylated AtExo70B1 at Ser107, Ser111, Ser248, Thr309, and Thr364. Moreover, XccXopP protected AtExo70B1 from AtCPK5 phosphorylation. Together these findings show that XccXopP is an effector, which not only functions as a novel serine/threonine kinase upon its host target AtExo70B1 but also protects the latter from the innate AtCPK5 phosphorylation, in order to bypass the host's immune responses. Data are available via ProteomeXchange with the identifier PXD041405.